Objectives: More and more elderly people around the world suffer from dementia and its
related behavioral and psychological symptoms. Second generation antipsychotic agents …

Abstract Setting Treating elderly patients with Alzheimer's disease (AD) and behavioral and
psychological symptoms of dementia (BPSD) is challenging due to the increased risk of …

Background/Purpose The USA Food and Drug Administration (FDA) issued warnings
regarding the use of antipsychotics in patients with dementia in 2003 and 2005. We aimed to …

Objectives: This randomized, double-blind, placebo-controlled trial examined the efficacy
and safety of quetiapine in the treatment of aggression, agitation, and psychosis in elderly …

Behavioral symptoms start to appear in mild and moderate dementia and become
increasingly severe with the progression of the disease. Agitation, aggressiveness, and …

Objectives The objectives of this study were to evaluate the efficacy, safety, and tolerability of
quetiapine for treating psychosis in patients with probable/possible Alzheimer disease and …

The purpose of this study was to assess the effect of quetiapine in the treatment of
behavioral and psychological symptoms of dementia (BPSD) in patients with senile …

Background Patients with dementia can impose a high burden on their carers, who may
experience high levels of psychological distress as symptoms of behavioral and …

Background: Neuropsychiatric symptoms (NPS) are distressing for patients with dementia,
often accelerating functional decline and nursing home placement. Medications such as …

Objective: To examine the use of quetiapine for sleep in patients with dementia admitted to a
geriatric psychiatry ward. Design: Retrospective cross-sectional study (January 2007 to …